2023
|
Invention
|
Water purification treatment device, water purification treatment method, and dye-containing cass... |
2021
|
Invention
|
Methods and apparatuses for modeling adamts13 and von willebrand factor interactions. Aspects of ... |
|
Invention
|
Actriib binding agents and uses thereof.
The disclosure provides, among other aspects, neutraliz... |
|
Invention
|
Antibodies against phosphorylcholine.
The present invention relates to an antibody or antibody f... |
|
Invention
|
Antibodies binding to phosphorylcholine (pc) and/or pc conjugates.
The present invention relates... |
|
Invention
|
Plasma kallikrein inhibitors and uses thereof for treating acute respiratory distress syndrome. P... |
2020
|
Invention
|
Methods and apparatuses for modeling, simulating, and treating hereditary angioedema. Aspects of ... |
|
Invention
|
Methods for quantitation of functional c1 esterase inhibitor (fc1-inh). Methods for quantitation ... |
|
Invention
|
Lateral flow immunoassay for measuring functional c1-esterase inhibitor (c1-inh) in plasma sample... |
|
Invention
|
Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack.
Provid... |
|
Invention
|
Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack. Provided... |
2018
|
Invention
|
Inhibitors of plasma kallikrein and uses thereof. e.g.e.ge.g., edema) with the compounds in a sub... |
|
G/S
|
Pharmaceutical preparations for the treatment of hereditary angioedema. |
|
G/S
|
Pharmaceutical preparations for the treatment of hereditary angioedema. |
|
G/S
|
Pharmaceutical preparations for the treatment of hereditary
angioedema. |
2017
|
G/S
|
Pharmaceutical preparations for the treatment of hereditary angioedema |
|
Invention
|
Protein biomarkers for diseases associated with the contact activation system. Provided herein ar... |
|
Invention
|
Rna biomarkers for hereditary angioedema. Provided herein are methods and kits for analyzing a bi... |
|
Invention
|
Metabolite biomarkers for diseases associated with the contact activation system. Provided herein... |
|
Invention
|
Plasma kallikrein binding proteins.
Plasma kallikrein binding proteins and methods of using such... |
|
G/S
|
Pharmaceutical preparations for the treatment of hereditary angioedema |
|
G/S
|
Pharmaceutical preparations for the treatment of hereditary angioedema, administered by injection. |
|
Invention
|
Water purifier and method for adjusting chlorine concentration in purified water. [Problem] To pr... |
2016
|
Invention
|
Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk)... |
|
Invention
|
Immunoassay to detect cleaved high molecular weight kininogen. The present disclosure provides im... |
|
Invention
|
Evacuated blood collection tubes containing protease inhibitors for the assessment of contact sys... |
|
Invention
|
Polynucleotides encoding an actriib antibody. The disclosure provides, among other aspects, neutr... |
|
Invention
|
A monoclonal antibody inhibitor of factor xiia. Disclosed herein are anti-Factor Xlla antibodies ... |
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for the treatment of hereditary angioedema. |
|
Invention
|
Water purifier. [Problem] To provide a water purifier capable of suppressing corrosion and microo... |
|
Invention
|
Plasma kallikrein inhibitors and uses thereof for preventing hereditary angioedema attack. Provid... |
2015
|
Invention
|
Bispecific antibodies against plasma kallikrein and factor xii. Described herein are bispecific a... |
|
Invention
|
Fc receptor binding proteins.
This disclosure provides, inter alia, proteins that bind to FcRn, ... |
|
G/S
|
Pharmaceutical preparations; Pharmaceutical preparations for the treatment of angioedema. Pharmac... |
|
Invention
|
Compositions and methods for treating ophthalmic disorders.
The present invention relates to com... |
|
Invention
|
Multivalent constructs for therapeutic and diagnostic applications.
The invention provides compo... |
|
Invention
|
Compositions and methods for treatment of diabetic macular edema. Disclosed herein are compositio... |
|
Invention
|
Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema. Provided h... |
2014
|
Invention
|
Methods of constructing libraries comprising displayed and/or expressed members of a diverse fami... |
|
Invention
|
Diagnosis and treatment of autoimmune diseases. Methods, kits and compositions for diagnosing and... |
|
Invention
|
Assays for determining plasma kallikrein system biomarkers. Methods and assays for determining th... |
|
Invention
|
Anti-plasma kallikrein antibodies.
Disclosed herein are antibodies capable of binding to plasma ... |
|
Invention
|
Anti-plasma kallikrein antibodies. Disclosed herein are antibodies capable of binding to plasma k... |
2011
|
G/S
|
Pharmaceutical preparations for the treatment of angioedema. |
2010
|
G/S
|
Pharmaceutical preparations for the treatment of angioedema. |
|
G/S
|
Providing information in the field of angioedema; Providing health information; Providing medical... |
|
G/S
|
Providing information in the field of angioedema; Providing a web site featuring news and informa... |
2008
|
G/S
|
Pharmaceutical preparations for the treatment of angioedema |
2004
|
G/S
|
Providing information about pharmaceutical research and clinical trials by means of an Internet w... |
|
G/S
|
Pharmaceutical compounds for the treatment of acute and chronic inflammatory disorders and condit... |
2003
|
G/S
|
Providing medical information and health care information to improve understanding by health care... |
1998
|
G/S
|
Pharmaceutical compounds and diagnostic compounds. Purification apparatus and parts therefor for ... |